Skip to main content
. 2024 Jun 7;11:1407138. doi: 10.3389/fcvm.2024.1407138

Table 3.

Compare two drug response in hiPSC-CM.

Drug EC50 95% CI HRM
Isoprenaline 0.018 μM 0.008825–0.0403 μM 100.60 ± 5.95%
Synephrine 3.314 μM 1.751–9.806 μM 40.74 ± 7.27%

hiPSC-CM, human induced pluripotent stem cell derived cardiomyocyte; NRCM, neonatal rat cardiomyocyte; 95% CI, 95% confidence interval; HRM, change of heart rate at maximal.